The effects of Evodiamine on the proliferation and apoptosis of pancreatic cancer SW1990 cells in vivo and in vitro

Hui CHEN,Zhaohong WANG,Long CHEN,Hengwei FAN,Bin ZHOU,Lubai XU,Hongfei TONG

DOI: https://doi.org/10.3969/j.issn.2095-9400.2017.06.009

2017-01-01

Abstract:Objective: To investigate the effects of Evodiamine on the proliferation and apoptosis of pan-creatic cancer SW1990 cells. Methods: Pancreatic cancer SW1990 cells were mixed with different concentra-tions of Evodiamine (0, 5, 10, 20, 40, 80 μmol/L) after 12, 24, 48 hours respectively. The SW1990 cells' prolif-eration was detected by cell counting Kit-8 (CCK-8). The SW1990 cells' cycle was detected with flow cytometry test. Nude mouse models were established with orthotopic transplantation tumor, which were injected with differ-ent concentrations of Evodiamine for 2 weeks. The orthotopic transplantation tumor's weight was measured after sacrificed. The expression of Active Caspase-3 and Active Caspase-8 in tumor tissues was detected by Western blot and immunohistochemistry. Results: Evodiamine inhibited the proliferation effect of SW1990 cells by con-centration and time dependence. The quantity of pancreatic cancer SW1990 cells in G2/M phase significantly increased. The expressions of Active Caspase-3 and Active Caspase-8 protein significantly increased. With in-creasing of Evodiamine concentrations, the inhibiting effect on the nude mouse's growth of pancreas transplanta-tion tumor was more remarkable and the expressions of Active Caspase-3 and Active Caspase-8 increased much more obviously in the tumor tissues. Conclusion: Evodiamine can significantly inhibit human pancreatic cancer SW1990 cells' proliferation with concentration and time dependence. Its mechanism may retard the growth of pancreatic cancer cells in G2/M phase. In the meantime, Evodiamine can activate Caspase-8 and Caspase-3, then promote the apoptosis of pancreatic cancer cells.